- In March 2020, EA Pharma Co., Ltd., in collaboration with its parent company Eisai Co., Ltd., launched “Actonel 17.5 mg tablets,” which received approval from the Ministry of Health, Labour and Welfare (MHLW) for the treatment of Paget's disease of bone. This launch represents a significant advancement in therapeutic options for managing this condition. By providing a targeted treatment, the companies aim to improve patient outcomes and enhance the overall management of Paget's disease
- In May 2021, Leucadia Pharmaceuticals Inc. introduced its FDA-approved generic product, Calcitonin Salmon Injection, USP, Synthetic. This injection is therapeutically equivalent to MIACALCIN and is indicated for the treatment of osteoporosis in postmenopausal women as well as for Paget's disease. Additionally, it is used in the early management of hypercalcemic emergencies, providing a rapid decrease in serum calcium levels when necessary
Frequently Asked Questions
The market is segmented based on Global Paget’s Disease Treatment Market Segmentation, By Route of Administration (Oral, Intravenous, and Topical), Treatment Type (Actonel, Reclast, Zoledronic Acid, Fosamax, Miacalcin, Aredia, Calcitonin, Zometa, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug-Class (Bisphosphonates, Calcitonin Analogues, Calcium Supplements, Vitamin-D Supplements, and Analgesics) – Industry Trends and Forecast to 2032
.
The Global Pagets Disease Treatment Market size was valued at USD 842.64 USD Million in 2024.
The Global Pagets Disease Treatment Market is projected to grow at a CAGR of 5.8% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
